Company Filing History:
Years Active: 2016
Title: Hansen Wong: Innovator in Pharmaceutical Formulations
Introduction
Hansen Wong is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of modified release formulations for oprozomib. His work is essential for improving the oral administration of this compound.
Latest Patents
Hansen Wong holds 1 patent for his innovative work. His patent, titled "Modified release formulations for oprozomib," focuses on creating modified release pharmaceutical formulations, including extended release solid dosage forms such as tablets. These formulations are designed for the effective oral administration of oprozomib or its pharmaceutically acceptable salts to human or animal subjects.
Career Highlights
Hansen Wong is currently employed at Onyx Therapeutics, Inc., where he continues to advance his research in pharmaceutical sciences. His expertise in formulation development has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Hansen has collaborated with talented individuals such as Mouhannad Jumaa and Tony Muchamuel. These partnerships have fostered innovation and contributed to the success of their projects.
Conclusion
Hansen Wong's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His work on modified release formulations for oprozomib is a testament to his dedication to improving patient care through advanced drug delivery systems.